peg-IFNβ-1a
Showing 1 - 25 of 3,127
Learn About Interferon-beta Exposure of Pregnant Women During
Not yet recruiting
- Multiple Sclerosis (MS)
- Avonex (IFNβ-1-a, Biogen Netherlands B.V)
- +5 more
-
Multiple Locations, Finland
- +1 more
Sep 19, 2023
Colonoscopy Trial in Chendu (100 ml lactulose combined with 1 L PEG, 100 ml lactulose combined with 2 L PEG, 200 ml lactulose)
Completed
- Colonoscopy
- 100 ml lactulose combined with 1 L PEG
- +3 more
-
Chendu, Sichuan, Chinawest china fourth hospital of Sichuan university
Dec 29, 2022
COVID-19 Virus Infection Trial in Milano (Interferon-ß-1a, Standard of Care (SOC))
Terminated
- COVID-19 Virus Infection
- Interferon-ß-1a
- Standard of Care (SOC)
-
Milano, ItalyIRCCS Ospedale San Raffaele
Apr 28, 2021
1L-PEG-Asc Solution for Bowel Preparation in"Open Access"
Completed
- Bowel Preparation
- use of a very low-volume 1L-PEG plus ascorbate (plenvu) or low-volume 2L-PEG plus ascorbate (moviprep) for bowel preparation in open access colonoscopy
-
Carpi, Modena, ItalyAzienda USL Modena
Feb 15, 2022
Real Word Evidence With 1L Polyethylene Glycol+ Ascorbic Acid in
Completed
- Colon Cancer
- +2 more
- 1L PEG + ASCORBIC ACID
-
Guimarães, Portugal
- +11 more
May 25, 2022
Small Cell Lung Cancer Trial in Worldwide (ADI-PEG 20 (Arginine deiminase pegylated))
Terminated
- Small Cell Lung Cancer
- ADI-PEG 20 (Arginine deiminase pegylated)
-
New York, New York
- +7 more
Oct 3, 2022
Chronic Hepatitis b, Anti-PD-1 Antibody, Peg-IFNa Trial in Chongqing (Anti-PD-1 antibody, NAs, Peg-IFNa)
Not yet recruiting
- Chronic Hepatitis b
- +2 more
- Anti-PD-1 antibody
- +2 more
-
Chongqing, Chongqing, ChinaThe 2nd affiliated Hospital of Chongqing Medical University
Mar 14, 2023
Arginase I Deficiency, Hyperargininemia Trial (Pegzilarginase)
Not yet recruiting
- Arginase I Deficiency
- Hyperargininemia
- (no location specified)
Jan 6, 2023
B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Lymphoblastic Lymphoma Trial
Not yet recruiting
- B Acute Lymphoblastic Leukemia
- +5 more
- Biospecimen Collection
- +4 more
- (no location specified)
Oct 28, 2022
Multiple Sclerosis Trial in Worldwide (Ofatumumab, First line DMT)
Recruiting
- Multiple Sclerosis
- Ofatumumab
- First line DMT
-
Bayonne, Bayonne Cedex, France
- +42 more
Jul 25, 2022
Brain Cancer, Pituitary Adenoma Trial in New York (89Zr-DFO-cRGDY-PEG-Cy5-C' dots PET Imaging, Blood and Urine samples)
Recruiting
- Brain Cancer
- Pituitary Adenoma
- 89Zr-DFO-cRGDY-PEG-Cy5-C' dots PET Imaging
- Blood and Urine samples
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 11, 2022
Oral Cancer Trial in Cairo (Quercetin 3,3',4',5,6-Pentahydroxyflavone,
Not yet recruiting
- Oral Cancer
- Quercetin 3,3',4',5,6-Pentahydroxyflavone, 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one
- +2 more
-
Cairo, Egypt11 Saraya El Manial
Jul 8, 2022
Mesothelioma Trial in Worldwide (ADI-PEG 20 plus Pem Cis, Placebo plus Pem Cis)
Completed
- Mesothelioma
- ADI-PEG 20 plus Pem Cis
- Placebo plus Pem Cis
-
Phoenix, Arizona
- +44 more
Sep 30, 2022
Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Houston (Paclitaxel, Carboplatin, Bevacizumab)
Recruiting
- Ovarian Cancer
- +2 more
- Paclitaxel
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Feb 13, 2023
Hepatocellular Carcinoma Trial in Hong Kong (pegylated recombinant human arginase)
Completed
- Hepatocellular Carcinoma
- pegylated recombinant human arginase
-
Hong Kong, Hong KongPrince of Wales Hospital, the Chinese University of Hong Kong
Aug 5, 2021
Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Mixed Phenotype Acute Leukemia
Not yet recruiting
- Recurrent Acute Leukemia of Ambiguous Lineage
- +5 more
- Biospecimen Collection
- +12 more
- (no location specified)
Mar 8, 2023
Brain Tumor, Brain Tumor, Recurrent, Brain Tumor, Refractory Trial in Memphis (Prexasertib, Cyclophosphamide, Gemcitabine)
Active, not recruiting
- Brain Tumor
- +12 more
- Prexasertib
- +4 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 20, 2022
Colon Disease Trial in Bologna (NER1006, MoviPrep, Macrogol 400)
Not yet recruiting
- Colon Disease
- NER1006
- +2 more
-
Bologna, ItalyPoliclinico Sant'Orsola-Malpighi
Jan 12, 2021
Cancer, Pediatric Solid Tumor, Pediatric AML Trial in Australia, United Kingdom (PEG- BCT-100)
Completed
- Cancer
- +3 more
- PEG- BCT-100
-
Adelaide, Australia
- +13 more
Sep 1, 2022
Critical Illness, Malnutrition, Gastrostomy Trial in Roanoke (noFast: Start tube feeds within 1 hour of procedure)
Recruiting
- Critical Illness
- +6 more
- noFast: Start tube feeds within 1 hour of procedure
-
Roanoke, VirginiaCarilion Roanoke Memorial Hospital
Oct 18, 2021
B Acute Lymphoblastic Leukemia Trial (procedure, biological, drug, radiation)
Not yet recruiting
- B Acute Lymphoblastic Leukemia
- Biospecimen Collection
- +19 more
- (no location specified)
Nov 8, 2023
Rhegmatogenous Retinal Detachment, Proliferative Vitreoretinopathy Trial in Philadelphia (Netarsudil 0.02% Ophthalmic Solution
Not yet recruiting
- Rhegmatogenous Retinal Detachment
- Proliferative Vitreoretinopathy
- Netarsudil 0.02% Ophthalmic Solution [RHOPRESSA]
- Glycerin 0.2%/Hypromellose 0.2%/Peg 1%/Soln,Oph,Ud
-
Philadelphia, PennsylvaniaWills Eye Physicians - Mid Atlantic Retina
Dec 13, 2022
Hepatitis C Trial in Rotterdam (Peginterferon alfa-2a, Interferon alfa-2a, Ribavirin)
Completed
- Hepatitis C
- Peginterferon alfa-2a
- +2 more
-
Rotterdam, NetherlandsErasmus Medical Center
Aug 26, 2021